2025-523861-58-00
Recruiting
Phase 1
A clinical study of MK-6050 in healthy people (MK-6050-001)
Merck Sharp & Dohme LLC1 site in 1 country32 target enrollmentStarted: November 12, 2025Last updated:
Overview
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 32
- Locations
- 1
Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Irving Ling
Scientific
Merck Sharp & Dohme LLC
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
A clinical study of MK-6916 in healthy people (MK-6916-006)2025-521487-36-00Merck Sharp & Dohme LLC40
Not yet recruiting
Phase 1
A clinical study of MK-5661 in healthy people (MK-5661-007)2024-520229-35-00Merck Sharp & Dohme LLC16
Completed
Phase 1
A clinical study of MK-6552 in healthy adults (MK-6552-002)2023-504954-37-00Merck Sharp & Dohme LLC64
Completed
Phase 1
A clinical study of MK-6916 in healthy people (MK-6916-002)2024-516899-15-00Merck Sharp & Dohme LLC40
Completed
Phase 1
A clinical study of MK-4646 in healthy people (MK-4646-002)2024-516626-63-00Merck Sharp & Dohme LLC32